Morpholine → 2',4'-Difluoro-N-(3-(2-hydroxy-1-morpholinoethyl)phenyl)biphenyl-4-sulfonamide
Reaction equation
[F:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[C:9]1[CH:14]=[CH:13][C:12]([S:15]([NH:18][C:19]2[CH:24]=[CH:23][CH:22]=[C:21]([CH:25]3[CH2:27][O:26]3)[CH:20]=2)(=[O:17])=[O:16])=[CH:11][CH:10]=1.[NH:28]1[CH2:33][CH2:32][O:31][CH2:30][CH2:29]1>CO>[F:1][C:2]1[CH:7]=[C:6]([F:8])[CH:5]=[CH:4][C:3]=1[C:9]1[CH:14]=[CH:13][C:12]([S:15]([NH:18][C:19]2[CH:24]=[CH:23][CH:22]=[C:21]([CH:25]([N:28]3[CH2:33][CH2:32][O:31][CH2:30][CH2:29]3)[CH2:27][OH:26])[CH:20]=2)(=[O:17])=[O:16])=[CH:11][CH:10]=1Participants
4
Procedure
Using a method analogous to Method D, using 2′,4′-difluoro-N-(3-(oxiran-2-yl)phenyl)biphenyl-4-sulfonamide and 1 M morpholine in methanol, a mixture of regioisomers was obtained. Reverse-phase HPLC was used to purify the mixture and the title compound was obtained as a pale orange powder from the mixture of isomers as gave ABD785. 1H NMR (300 MHz, CDCl3): δ 2.75-2.81 (3H, m), 3.30 (1H, m), 3.60-3.95 (8H, m), 4.10-4.20 (1H, m), 6.80-7.10 (3H, m), 7.20-7.30 (2H, m), 7.35-7.45 (2H, m), 7.57 (2H, d, J=8 Hz) and 7.91 (2H, d, J=8 Hz). MS, m/z: Calcd, 474.142. Found, 474.58 (M).
Workup
- additiona mixture of regioisomers
- customwas obtained
- customto purify the mixture
Sources & evidence
- ORD record
- ord-7d41a483457944afbcf201fa8f9ae485
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08207167B2
Reaction notes
Loading…